Cargando…
Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity
The increasing relevance of improved therapeutic monoclonal antibodies (mAbs) to treat neurodegenerative diseases has strengthened the need to reliably measure their brain pharmacokinetic (PK) profiles. The aim of this study was, therefore, to absolutely quantify the therapeutic antibody ocrelizumab...
Autores principales: | Altendorfer-Kroath, Thomas, Hummer, Joanna, Kollmann, Denise, Boulgaropoulos, Beate, Raml, Reingard, Birngruber, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383368/ https://www.ncbi.nlm.nih.gov/pubmed/37514066 http://dx.doi.org/10.3390/pharmaceutics15071880 |
Ejemplares similares
-
Assessment of Blood-Brain Barrier Function and the Neuroinflammatory Response in the Rat Brain by Using Cerebral Open Flow Microperfusion (cOFM)
por: Ghosh, Arijit, et al.
Publicado: (2014) -
Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence
por: Bodenlenz, Manfred, et al.
Publicado: (2016) -
Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution
por: Bodenlenz, Manfred, et al.
Publicado: (2016) -
Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion
por: Bodenlenz, Manfred, et al.
Publicado: (2020) -
Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood–brain barrier in leptin resistant mice
por: Kleinert, Maximilian, et al.
Publicado: (2018)